Today's Top Alzheimer's News


TODAY: Together with WomenAgainstAlzheimer’s, we are hosting a Twitter Chat with USA Today to elevate the conversation about Alzheimer’s impact on women. We hope you can join us this Wednesday 11/16 from 1 – 2 pm ET to amplify our collective voice! What should you do? Jump on Twitter at 1 pm ET and use the hashtag #hope4alz to respond to the moderator, ask questions, and provide your own thoughts and views.

Today: Dr. Laura Baker will share with us information on the EXERT Study: Building Memories through Exercise. EXERT will be conducted at YMCAs across the country to see whether physical exercise can slow memory loss and other symptoms of Alzheimer’s disease. We will also learn about the research that suggests why exercise might be beneficial for the brain. Click here to sign up for the Alzheimer’s Talks call on Wednesday, November 16, at 3 p.m. Eastern!

Press Release: A multigenerational movement to defeat Alzheimer’s disease, buoyed by the partnership of UsAgainstAlzheimer’s and a host of national, state and local Alzheimer’s-serving organizations, was catalyzed during this fall’s National Alzheimer’s Summit in Washington, DC, proving to be a decisive moment in a fight against a disease that is the nation’s third-leading cause of death.  


A November 16, 2016 article reported that Claudia Satizabal, PhD, of Boston University School of Medicine, has received a grant to study how obesity affects brain aging and Alzheimer’s disease. According to the Dr. Satizabal, “Populations worldwide are facing an obesity epidemic, and these same populations are aging and will contribute to the growing prevalence of dementia and [Alzheimer’s disease]. Therefore, it becomes imperative to understand the mechanisms by which obesity increases the risk of dementia and [Alzheimer’s disease], which may help develop health policies and treatment strategies to diminish the consequences of obesity in late life.”

A November 15, 2016 Bloomberg article reported that “Medical research groups are confident that President-elect Donald Trump will support their effort to increase NIH funding in 2017 by nearly $3 billion.”

A November 15, 2016 Boston Herald article highlighted the efforts of Mass General researchers to develop an olfactory test for Alzheimer’s. According to the article, “A simple smell test developed by local researchers could help predict the onset of Alzheimer’s disease as far as 15 years in advance, allowing doctors to intervene before the devastating memory disease takes hold.”

A November 15, 2016 Investors Business Daily article highlighted looming news in the Alzheimer’s drug market. According to the article, “Outside the Trump effect, analysts have seized on Eli Lilly's solanezumab as a key driver for the industry, including rival Biogen (BIIB), which has a similar Alzheimer's drug on the line. Solanezumab is an antibody that could act as a neuroprotector for patients with Alzheimer's disease.”


^ Back to Top